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INTRODUCTION  
Malaria is a major public health problem in endemic 
tropical regions. It affected 212 million new people and 
caused 429,000 deaths in 2015 in the world.1 The 
mortality in developed countries was low. The 
neurological failure, acute respiratory distress 
syndrome and mechanical ventilation2, age, and 
hyperparasitaemia3 were the factors associated with 
mortality. But in Africa, the mortality was around 16 to 
32%.4,5 Age > 65 years, coma, seizures, macroscopic 
hemoglobinuria5 and cardiogenic shock were the poor 
prognostic factors.5 Our aim is to determine the factors 
of poor prognosis of this disease. 
 
MATERIALS AND METHOD  
This is an analytical descriptive retrospective study 
conducted over a period of 24 months (June 2015 to May 
2017). It was performed in Intensive Care Unit of 
University Hospital Center of Joseph Raseta 
Befelatanana. 
 
Patients’ inclusion criteria was: 18 years of age, those 
who were diagnosed and tested positive for 
Plasmodium by peripheral blood smears, quantitative 
buffy coat test, had one or more criteria of severe 
malaria as per the Recommendations for clinical 
practice (2007).6 
 
 
 
 
Variables included age, gender, comorbid condition, 
severe malaria severity criteria’s, treatment, the 
duration of hospitalisation and mortality. 
 
The study was reviewed and approved by the Ethical 
Review Board of the Medical Intensive Care Unit of the 
University Hospital Center of Joseph Raseta 
Befelatanana. Data were collected and entered in 
Microsoft Excel 2016. Continuous variables were 
represented by mean and standard deviation, and 
categorical variables were represented by number and 
frequency. The t-student test was used to analyse 
continuous variables and chi-square test for analysis of 
categorical variable. The p value was considered as 
significant if less than 0.05.  
 
RESULT 
A total of 56 patients were reviewed. The mean age was 
30 ± 11 years. Out of the total subjects, 48 were males. 
Sex ratio was found to be 6. A total of 06 cases had 
respiratory comorbidities. 
 
Twenty nine (52%) developed neurological failure. The 
circulatory failure and jaundice were observed in 17 
(30%) and 16 (29%) cases respectively. Severe anaemia 
was    present   in   14 (25%)    cases,  5(9%)    cases   had  
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hyperparasitaemia.  
 
47 (84%) patients received quinine. Twelve (21%) cases 
were given norepinephrine. The average length of ICU 
stay was 3.55 ± 2.07 days. The mortality proportion was 
32% (18 cases).  (Table 1) 
 
VARIABLES RESULTS 
Age (years) 
Male / female gender 
Comorbidities conditions 
    None 
   Cardiovascular and      
   metabolic 
   Respiratory 
Severity criteria of malaria6  
Neurological failure 
Cardio-circulatory failure 
Respiratory failure 
Jaundice  
Renal insufficiency 
Repeated convulsions  
Haemorrhage 
Severe anaemia 
Hypoglycemia 
Hyperparasitaemia  
Quinine / artesunate 
Dialysis 
Mechanical ventilation  
Duration of hospitalisation 
Mortality (days) 
30 ± 11 
48/8 
 
46 (82) 
2 (4) 
 
6 (11) 
 
29 (52) 
17 (30) 
12 (21) 
14 (25) 
9 (16) 
14 (25) 
10 (18) 
14 (25) 
4 (7) 
5 (9) 
47 (84) / 9 (16) 
0 (0) 
0 (0) 
18 (32) 
3.55 ± 2.07 
 
 
In multivariate analysis, neurological failure, jaundice, 
renal insufficiency and use of catecholamine were 
factors associated with poor prognosis (Table 2). 
  
DISCUSSION 
In this study, neurological failure was by far the most 
common. The mortality proportion was 32%. 
Neurological failure, jaundice, renal insufficiency and 
use of catecholamine represented as mortality risk 
factors. 
 
The mortality proportion was 32%: 16 to 33% in 
Africa4,5,7, low in India8,9 and developed country2,3,10,11. 
This difference could be explained by the untimely 
diagnosis and treatment of patients.12 All patients were 
transferred from rural endemic regions to the hospital. 
The neurological failure was the most common 
sign3,5,7,13 and was among the factors of poor prognosis: 
a result confirmed by the literature.3,9,13 
 
Jaundice has been reported as a risk factor: result 
confirmed by literature.13,14 It is due to liver 
dysfunction11 and lysis of red blood cells. 
 
The renal insufficiency was observed as a factor of poor 
prognosis: a result confirmed by some  authors.5,9,11 
None of our patients underwent haemodialysis because 
they had no money. The haemodialysis rate varied from 
10 to 35% in the literature,3,9-11 with acute renal failure in 
48% of subjects.9,15 The lack of dialysis increased death 
rate.16 The aetiology was multifactorial including 
hypovolemia, disseminated intravascular coagulation, 
haemolysis and hyperbilirubinemia.17  
 
The use of amines was a risk factor associated with 
mortality and consistent with other reported series.3,4,9 
 
This retrospective study predicted the poor factors 
associated with death in severe malaria. It was the first 
study conducted in a medical ICU of Madagascar. 
Despite the small sample size, it did not predict the 
overall assessment of the Malagasy population in 
intensive care.  
 
CONCLUSION  
The morbidity and mortality of malaria remains a major 
problem in tropical countries. No study evaluated 
factors associated with poor prognosis in Madagascar. 
Mortality remains high in our study with factors 
associated with poor prognosis such as jaundice, 
neurological failure, use of catecholamine and renal 
insufficiency. Table 1. Clinical & Microbiological Characteristics and 
Treatment of Severe Malaria 
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VARIABLES 
PATIENTS SURVIVORS 
(N = 38) 
PATIENTS NON SURVIVORS 
(n= 18) 
 
p-VALUE 
Age 
Male gender 
 
Cardio-circulatory failure 
Neurological failure 
Jaundice  
Renal insufficiency  
Repeated convulsions 
Haemorrhage 
Severe anaemia 
Hypoglycemia 
Quinine 
Catecholamine 
29 ± 11 
32 
 
9 
13 
6 
2 
8 
5 
10 
3 
31 
2 
31 ± 12 
16 
 
8 
16 
10 
7 
6 
5 
5 
1 
16 
5 
.5151 
.6055 
 
0.0777 
0.0001 
0.0016 
<0.0001 
.2486 
.1922 
.5921 
.4532 
.6290 
0.0013 
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